3.51 USD
↘ 0.15 (4.10%)AT CLOSE (03:59 PM EDT)
Edesa Biotech, Inc. Common Shares
EDSANASDAQ • USD
3.69
↗ 0.18 (4.99%)
POST MARKET (AS OF 05:24 PM EDT)
Post Market
AS OF 05:24 PM EDT
3.69
↗ 0.18 (4.99%)
Market: OPEN
Shares of Edesa Biotech, Inc. Common Shares (EDSA) are trading at $3.69. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, EDSA trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Oct 9, 2026.
Open?$3.61
High?$3.76
Low?$3.49
Prev. Close?$3.66
Volume?35.5K
Avg. Volume?41.5K
VWAP?$3.62
Rel. Volume?0.86x
Bid / Ask
Bid?$2.85 × 100
Ask?$4.34 × 100
Spread?$1.49
Midpoint?$3.59
Valuation & Ratios
Market Cap?35.3M
Shares Out?9.6M
Float?3.6M
Float %?51.1%
P/E Ratio?N/A
P/B Ratio?4.00
EPS?-$1.46
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
Employees
17
Market Cap
35.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2010-06-09
Address
100 SPY COURT
MARKHAM,
Phone: (905) 475-1234
MARKHAM,
Phone: (905) 475-1234
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?74
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.30Distress
Confidence?45%Low
Short InterestElevated
Short % of Float?5.66%Elevated
Short Interest?203.6K
Days to Cover?4.8
Free Float3.6M
Avg Daily Volume42.3K
Settlement Date2026-09-30
Financial Health
Current Ratio?2.76Strong
Quick Ratio?2.76Strong
Cash Ratio?2.64Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?4.00FAIR▾
Peers100
S&P44
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.7CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-160.1%WEAK▾
S&P3
ROA?-110.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-8907623
Enterprise Value?$25.0M
Fundamentals ratios updated end of day